
Rabepac L 75mg/20mg Capsule SR
Manufacturer
Pyrocare Pharmaceuticals Pvt Ltd
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Key Information
Short Description
Rabepac L 75mg/20mg Capsule SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux), intestinal ulcers, and irritable bowel syndrome.
Dosage Form
Capsule SR
Introduction
Rabepac L 75mg/20mg Capsule SR is taken with or without food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your healthcare team know about all other medications you are taking as some may affect or be affected by this medicine.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Rabepac L 75mg/20mg Capsule SR is to be taken empty stomach.
Safety Information
Side Effects
The most common side effects are nausea, stomach pain, diarrhea, flatulence, constipation, headache, weakness, and flu-like symptoms.
Alcohol Warning
It is unsafe to consume alcohol with Rabepac L 75mg/20mg Capsule SR.
Breastfeeding Warning
Information regarding the use of Rabepac L 75mg/20mg Capsule SR during breastfeeding is not available. Please consult your doctor.
Pregnancy Warning
Rabepac L 75mg/20mg Capsule SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Rabepac L 75mg/20mg Capsule SR is a combination of two medicines: Levosulpiride and Rabeprazole.
Quick Tips
Do not consume alcohol while taking Rabepac L 75mg/20mg Capsule SR as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Rabepac L 75mg/20mg Capsule SR for longer than prescribed.
Related Medicines

Colosafe-L Capsule SR

Rablet L Capsules

Veloz L Capsule

Rabonik Plus Capsule SR

Ansuper-Plus Capsule SR

Razo-L Capsule

Acera-L Capsule SR

Rabemac LS Capsule

Rabilyn LS 75mg/20mg Capsule SR

Rabiwin LS 75mg/20mg Capsule SR
Frequently asked questions
What is the recommended dosage and administration schedule for Rabepac L 75mg/20mg Capsule SR?
Take one capsule of Rabepac L 75mg/20mg Capsule SR daily on an empty stomach, as instructed by your healthcare provider.
What are the contraindications for using Rabepac L 75mg/20mg Capsule SR?
Avoid use of Rabepac L 75mg/20mg Capsule SR in patients with known allergies to any component or excipient of this medication.
Can Rabepac L 75mg/20mg Capsule SR cause dizziness?
Yes, some individuals may experience dizziness (e.g., faintness, weakness, unsteadiness) while using Rabepac L 75mg/20mg Capsule SR. If you feel lightheaded or dizzy, rest and resume your activities once you regain stability.
Does the use of Rabepac L 75mg/20mg Capsule SR increase fracture risk?
Some studies suggest a higher risk of fractures (especially in hip, wrist, or spine) during long-term treatment with Rabepac L 75mg/20mg Capsule SR at high doses. High dose may be defined as multiple daily doses and long-term therapy for one year or more.
Can I drive while taking Rabepac L 75mg/20mg Capsule SR?
Rabepac L 75mg/20mg Capsule SR can cause drowsiness, dizziness, or visual impairment. Do not operate vehicles or machinery until you have a clear understanding of how this medication affects your abilities.
How should I store and dispose of Rabepac L 75mg/20mg Capsule SR?
Store Rabepac L 75mg/20mg Capsule SR in its original container, sealed tightly. Follow the storage instructions provided on the packaging label or medication leaflet, and ensure proper disposal. Do not give this medication to pets, children, or unauthorized individuals.